Daniel Velazquez-Villoria

Daniel Velazquez-Villoria

Auto-generated profile, based on publicly available information

Daniel Velazquez-Villoria

Clínica Villoria, Vigo, Spain

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2020 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
MZMiguel Ángel Zapata
Miguel Ángel Zapata
SGSandra Banderas García
Sandra Banderas García
AMAdrian-Sanchez Montalva
Adrian-Sanchez Montalva
AFAnna Falcó
Anna Falcó
SOSusana Otero-Romero
Susana Otero-Romero
JGJose García-Arumí
Jose García-Arumí
Background Global pandemic SARS-CoV-2 causes a prothrombotic state without fully elucidated effects. This study aims to analyse and quantify the possible retinal microvascular abnormalities. Materials and methods Case–control study. Patients between 18 and 55 years old with PCR-confirmed SARS-CoV-2 infection within the last 3 months were included. Risk stratification: group 1—mild disease (asymptomatic/paucisymptomatic); group 2—moderate disease (required hospital admission with no acute respiratory distress) and group 3—severe disease (subjects who developed an acute respiratory distress were admitted in the intensive care unit and presented interleukin 6 values above 40 pg/mL). Age-matched volunteers with negative serology tests were enrolled to control group. A colour photograph, an optical coherence tomography (OCT) and an angiography using OCT centred on the fovea were performed. Results Control group included 27 subjects: group 1 included 24 patients, group 2 consisted of 24 patients and 21 participants were recruited for group 3. There were no funduscopic lesions, neither in the colour images nor in the structural OCT. Fovea-centred vascular density (VD) was reduced in group 2 and group 3 compared with group 1 and control group (control group vs group 2; 16.92 vs 13.37; p=0.009) (control group vs group 3; 16.92 vs .13.63; p=0.026) (group 1 vs group 2; 17.16 vs 13.37; p=0.006) (group 1 vs group 3; 17.16 vs 13.63 p=0.017). Conclusion Patients with moderate and severe SARS-CoV-2 pneumonia had decreased central retinal VD as compared with that of asymptomatic/paucisymptomatic cases or control subjects.

4 January 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JZJavier Zarranz-Ventura
Javier Zarranz-Ventura
ASAnna Sala-Puigdollers
Anna Sala-Puigdollers
DVDaniel Velazquez-Villoria
Daniel Velazquez-Villoria
MFMarc Figueras-Roca
Marc Figueras-Roca
SCSergio Copete
Sergio Copete
OGon behalf of the Hospital Clínic—Hospital Vall de Hebron Intravitreal Dexamethasone Implant study group
on behalf of the Hospital Clínic—Hospital Vall de Hebron Intravitreal Dexamethasone Implant study group
To evaluate the long-term cumulative probability of intraocular pressure (IOP) elevation with the intravitreal dexamethasone implant (IDI) when used to treat different indications: diabetic macular edema, uveitis, retinal vein occlusion. 705 IDI injections (429 eyes) were assessed and Kaplan-Meier graphs were generated to assess: the probability of different levels of IOP elevation (IOP≥21, ≥25 or ≥35 mmHg), IOP change ≥10 mmHg, initiation of IOP-lowering treatment, glaucoma surgery, IOP change with repeat injections and IOP elevation in eyes with glaucoma and ocular hypertension (OHT). The cumulative probability of IOP ≥21, ≥25 and ≥35 mmHg was 50%-60%, 25%-30% and 6%-7% at 12–24 months, respectively. The probability of initiating IOP-lowering medication was 31%-54% at 12–24 months. Glaucoma and OHT eyes had a higher probability of mild IOP elevation (≥21 mmHg, 65.1%, 75% and 57.8%, p = 0.01), yet a similar moderate (≥25 mmHg, 22.3%, 28% and 30.2%, p = 0.91) and severe elevation of IOP (≥35 mmHg, 3.7%, 7.1% and 4%, p = 0.71) as normal eyes. Glaucoma surgery was required in only 0.9% cases (4/429). At baseline, 8.8% of the treated eyes had glaucoma, 6.7% OHT and 16.9% were already on IOP-lowering medication. In the long-term (24 months), IOP elevation is common, generally mild (30% IOP, ≥25 mmHg) and well-tolerated, resolving with topical treatment (54%) and rarely requiring surgery (0.9%).

1 June 2017 in Archivos de la Sociedad Española de Oftalmología
Verified
Journal Article
Closed access
DVD. Velazquez-Villoria
D. Velazquez-Villoria
CMC. Macia-Badia
C. Macia-Badia
ASA. Segura-García
A. Segura-García
SIS. Pastor Idoate
S. Pastor Idoate
GAG. Arcos-Algaba
G. Arcos-Algaba
JGJ. García-Arumí
J. García-Arumí

2 September 2022 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
EAErnesto Alonso-Juárez
Ernesto Alonso-Juárez
DVDaniel Velázquez-Villoria
Daniel Velázquez-Villoria
Purpose: Nowadays the Implantable Collamer Lens (ICL – STAAR Surgical. Monrovia. CA) is a refractive surgical technique offered not only when laser corneal correction is not possible but also when the patient requires premium quality indexes and when dry eye is a concern. The use of ICL phakic lenses in low myopic patients is an emanate factor to study and analyze in order to determine treatment predictability and stability in such patients. In this paper, we conducted a 1-year follow-up study on patients with myopia below − 3.5D implanted with ICL lenses. Methods: This was a retrospective analytical study that includes patients with phakic ICL implantation from 2 independent clinics with a minimum follow-up of 12 months. Visual acuity, refractive outcomes, vault, and intraocular pressure (IOP) were assessed at 1, 6 and 12 months. Results: Eighty-two eyes from 82 patients were included in this analysis. Mean spherical equivalent was − 2.34 ± 0.82 (Range − 5.50 to − 1.00 D). Mean spherical implanted ICL power was − 3.04 ± 0.78 D. In 25 eyes (30.5%) a Toric-ICL (TICL) was implanted with a mean TICL cylinder power of +1.64± 0.64. Efficacy and security index remained stable for 12 months at 1.07 and 1.09, respectively. Mean vault at 12 months was 513.78 ± 262.87 μm and IOP was 15.63 ± 2.17 mmHg. Conclusion: Phakic Implantable Collamer Lens implantation in very low myopia is a predictable, stable, safe, and effective technique with high efficacy and security indexes. Low diopter Toric ICL is also an excellent option for refractive surgery in cases of low diopter astigmatism.

8 March 2021 in Eye
Verified
Journal Article
Closed access
PDF file
CBCarolina Bernal-Morales
Carolina Bernal-Morales
DVDaniel Velazquez-Villoria
Daniel Velazquez-Villoria
JCJuan Manuel Cubero-Parra
Juan Manuel Cubero-Parra
PKPearse Keane
Pearse Keane
DSDawn A. Sim
Dawn A. Sim
JZJavier Zarranz-Ventura
Javier Zarranz-Ventura

21 September 2024 in Eye
Verified
Journal Article
Closed access
PDF file
MPMartín Puzo
Martín Puzo
PCPilar Calvo-Perez
Pilar Calvo-Perez
FBFrancisco De Asís Bartol-Puyal
Francisco De Asís Bartol-Puyal
JSJORGE SANCHEZ-MONROY
JORGE SANCHEZ-MONROY
RMRuben Martin-Pinardel
Ruben Martin-Pinardel
JZJavier Zarranz-Ventura
Javier Zarranz-Ventura